Clinton A. Lewis, Jr.
Executive Vice President & Group President, International Operations, Commercial Development, Global Genetics & Aquatic Health, Zoetis Inc.
Clinton A. Lewis, Jr., 52, currently serves as executive vice president and group president responsible for international operations, commercial development, global genetics and PHARMAQ at Zoetis Inc., an NYSE-listed global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines that was spun off by Pfizer in 2013. Prior to being named to his current role in May 2015, Lewis previously served as president of international operations from 2015 to 2018 and as president of U.S. operations at Zoetis from 2013 to 2015. Prior to the formation of Zoetis, he served as president of U.S. operations at Pfizer Animal Health which he joined in 2007.
He joined Pfizer in 1988 in the human health pharmaceutical segment and held positions of increasing responsibility in various commercial operations and general management roles. He formerly served as chairman of the board for the Animal Health Institute (AHI), an industry trade association in the U.S., and served as treasurer for Animal Health Europe, an industry trade association in Europe. Director since November 4, 2017.